Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group

  1. Spanjaart, A.M.
  2. Ljungman, P.
  3. Tridello, G.
  4. Schwartz, J.
  5. Martinez-Cibrián, N.
  6. Barba, P.
  7. Kwon, M.
  8. Lopez-Corral, L.
  9. Martinez-Lopez, J.
  10. Ferra, C.
  11. Di Blasi, R.
  12. Ghesquieres, H.
  13. Mutsaers, P.
  14. Calkoen, F.
  15. Jak, M.
  16. van Doesum, J.
  17. Vermaat, J.S.P.
  18. van der Poel, M.
  19. Maertens, J.
  20. Gambella, M.
  21. Metafuni, E.
  22. Ciceri, F.
  23. Saccardi, R.
  24. Nicholson, E.
  25. Tholouli, E.
  26. Matthew, C.
  27. Potter, V.
  28. Bloor, A.
  29. Besley, C.
  30. Roddie, C.
  31. Wilson, K.
  32. Nagler, A.
  33. Campos, A.
  34. Petersen, S.L.
  35. Folber, F.
  36. Bader, P.
  37. Finke, J.
  38. Kroger, N.
  39. Knelange, N.
  40. de La Camara, R.
  41. Kersten, M.J.
  42. Mielke, S.
  43. Montrer des auteurs +
Revue:
Leukemia

ISSN: 1476-5551,  0887-6924

Année de publication: 2024

Volumen: 38

Número: 9

Pages: 1985-1991

Type: Article

DOI: 10.1038/S41375-024-02336-1 GOOGLE SCHOLAR lock_openAccès ouvert editor